The FDA said patients should not use the drugs outside of hospital settings or clinical trials after a review of literature and data from poison control centers and its adverse event reporting system found instances of heart arrhythmias, some of which were fatal.

LEAVE A REPLY

Please enter your comment!
Please enter your name here